ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 143 • 2015 ACR/ARHP Annual Meeting

    Fiber Optic Intubation in Patients with Rheumatoid Arthritis Who Had a Surgical Procedure

    Gurjot Basra1, Marylou Cardenas-Turanzas2, Tayab Andrabi3, Katy Elizabeth French3, Bobby Bellard3, William A Murphy Jr.4, Maria A. Lopez-Olivo5 and Maria E. Suarez-Almazor5, 1Baylor College of Medicine, Houston, TX, 2Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3Anesthesiology, The University of Texas, MD Anderson Cancer Center, Houston, TX, 4Radiology, The University of Texas, MD Anderson Cancer Center, Houston, TX, 5General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Fiber optic intubation is the preferred method of airway management during anesthetic procedures for patients with RA. The purpose of our study was to…
  • Abstract Number: 144 • 2015 ACR/ARHP Annual Meeting

    One-Year Costs Following Switching Versus Dose-Escalation Among Prevalent Tumor Necrosis Factor Inhibitors Used for Rheumatoid Arthritis

    Tao Gu1, Derek Tang2, Gaurav Deshpande1, Debra F Eisenberg1 and David J. Harrison3, 1HealthCore, Wilmington, DE, 2Amgen, Inc., Thousand Oaks, CA, 3Amgen Inc., Thousand Oaks, CA

    Background/Purpose: Switching a biologic treatment or escalating biologic doses are common approaches used upon biologic treatment failure. The objective of this study was to estimate…
  • Abstract Number: 145 • 2015 ACR/ARHP Annual Meeting

    Economic Burden of Switching to an Anti-Tumor Necrosis Factor (anti-TNF) Versus a Non-Tumor Necrosis Factor (non-TNF) Biologic Therapy Among Patients with Rheumatoid Arthritis

    Zheng-Yi Zhou1, Jenny Griffith2, Arijit Ganguli2, Ella Xiaoyan Du1 and Keith Betts1, 1Analysis Group, Inc., Boston, MA, 2AbbVie Inc., North Chicago, IL

    Background/Purpose: Real world studies comparing the healthcare utilization of anti-TNFs vs. non-TNFs as the next alternative after the failure of the first anti-TNF are scarce.…
  • Abstract Number: 146 • 2015 ACR/ARHP Annual Meeting

    Rates of Lipid Testing and Statin Prescription Filling Among U.S. Medicaid Recipients with SLE, 2007-2010

    Sarah Chen1, Michael A. Fischer2, Hongshu Guan3, Medha Barbhaiya4 and Karen H. Costenbader5, 1Beth Israel Deaconess Medical Center, Boston, MA, 2Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, 3Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 4Internal Medicine, Weill Cornell Medical College, New York, NY, 5Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Given high cardiovascular disease (CVD) risks in SLE patients, lipid testing and statin prescription are widely advocated for those with elevated risks. We examined…
  • Abstract Number: 147 • 2015 ACR/ARHP Annual Meeting

    Fatigue, Coping, Sleeping Disorders and Productivity Were Still Not Frequently Reported in Rheumatoid Arthritis Trials Published in 2014-2015: A Systematic Literature Review

    Levent Kilic1, Abdulsamet Erden1, Laure Gossec2 and Umut Kalyoncu1, 1Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Rheumatology, Pitié Salpetriere Hospital, Paris, France

    Background/Purpose: In a systematic literature review (SLR), frequency of patients reported outcomes (PROs) related with rheumatoid arthritis (RA) was evaluated between 2005 and 2007 (1).…
  • Abstract Number: 148 • 2015 ACR/ARHP Annual Meeting

    An Evaluation of the Virtual Monitoring Clinic, a Novel Nurse-Led Telemonitoring Service for Monitoring Patients with Stable Rheumatoid Arthritis

    Li-Ching Chew1, Julian Thumboo1, Hui Yang2 and Xiaohui Xin3, 1Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore, 2Division of Medicine, Singapore General Hospital, Singapore, Singapore, 3Academic Clinical Programme, Division of Medicine, Singapore General Hospital, Singapore, Singapore

    Background/Purpose: To study the clinical and patient reported outcomes of the Virtual Monitoring Clinic (VMC), which is novel nurse-led telemonitoring cum pharmacy medication home delivery…
  • Abstract Number: 149 • 2015 ACR/ARHP Annual Meeting

    Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus (SLE) Initiating Treatment with Belimumab in a US Commercially Insured Database: 2010-2014

    Deanna Hill1, Hong Kan2, Peter Egger3, David J. Chang4, Amanda Eudy1,5, Joe Maskell3 and Karen H. Costenbader6, 1Worldwide Epidemiology, GlaxoSmithKline, Collegeville, PA, 2Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC, 3Worldwide Epidemiology, GlaxoSmithKline, Stockley Park, United Kingdom, 4US Medical Affairs, GlaxoSmithKline, Philadelphia, PA, 5Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 6Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Belimumab, a B-lymphocyte stimulator, was FDA-approved March 2011 for the treatment of adult patients with active, autoantibody-positive SLE receiving standard of care (SOC) medications.…
  • Abstract Number: 150 • 2015 ACR/ARHP Annual Meeting

    A Preliminary Consensus on Core Outcome Domains for Total Joint Replacement Clinical Trials: An Omeract-Based Study

    Jasvinder A. Singh1 and Michael Dohm2, 1University of Alabama at Birmingham, Birmingham, AL, 2Orthopaedic Surgery, Univ of Arizona, Tucson, AZ, Tucson, AZ

    Background/Purpose: Outcomes Measures in Rheumatology Trials (OMERACT) has developed a framework based on the WHO’s International Classification of Functioning, Disability, and Health (ICF) conceptual model. …
  • Abstract Number: 151 • 2015 ACR/ARHP Annual Meeting

    Residual Synovitis in Ultrasound (US) Is Associated with an Evolution Towards Rheumatoid Arthritis  (RA) in Patients with Inflammatory Polyarthralgia without ANTI-Citrulinated Antibodies (ACPA)

    Pascal Zufferey1,2,3, Claudia Rebell Jr.4, Alexandre Dumusc5, Mauro lucini4, Juerg Hains6, Alexander K. So Sr.7 and Charles Benaim8, 1Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, 2Pierer Decler, Chuv, Lausanne, Switzerland, 3Rhu /Dal .Chuv, Rheumatology, Lausanne, Switzerland, 4DAL, RHU/CHUV, lausanne, Switzerland, 5RHU/CHUV, lausanne, Switzerland, 6DAL, RHU/CHUV, Lausanne, Syria, 7Service De Rhumatologie, CHUV, Lausanne, Switzerland, 8DAL, MPR, Lausanne, Switzerland

    Background/Purpose: In ACPA positive patients, subclinical synovitis as observed by US has been demonstrated in pre RA patients and seems to be predictive for future…
  • Abstract Number: 152 • 2015 ACR/ARHP Annual Meeting

    Anti-CCP Positive Patients without Clinical Synovitis Progress If Ultrasound Positive

    Jackie L. Nam1, Elizabeth M.A. Hensor1, Laura Hunt1, Philip G. Conaghan2, Richard J. Wakefield1 and Paul Emery3, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 3NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

    Background/Purpose: To determine whether ultrasound can identify which anti-cyclic citrullinated peptide (anti-CCP) antibody positive patients with musculoskeletal (MSK) symptoms and without clinical synovitis progress to…
  • Abstract Number: 153 • 2015 ACR/ARHP Annual Meeting

    Utility of Ultrasound Synovitis Assessment As a Predictor of Flares in Clinically Inactive Joints

    Tomas Cazenave1, Christian A. Waimann2, Natalia Zamora1, Gustavo Citera1 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Hospital Dr. Hector Cura, Olavarria, Argentina

    Background/Purpose: Several ultrasound (US) studies have shown a high frequency of inflammation in clinically inactive joints of rheumatoid arthritis (RA)patients. There is controversy in the…
  • Abstract Number: 154 • 2015 ACR/ARHP Annual Meeting

    Clinical Features of Fibromyalgia in Patients with Rheumatoid Arthritis Predict Lower Power Doppler Scores on Ultrasound

    Aneela Mian1, Khaldoun Chaabo2, Julekha Wajed3, Bruce W. Kirkham4 and Toby Garrood5, 1Academic Rheumatology, King's College London, London, United Kingdom, 2Rheumatology, Guy's and St Thomas NHS Trust, London, United Kingdom, 3Rheumatology, Guys' and St Thomas' NHS Trust, London, United Kingdom, 4Rheumatology, Guy's and St. Thomas' Foundation Hospital NHS Trust, London, United Kingdom, 5Rheumatology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

    Background/Purpose: Up to 20% of patients with RA have coexisting fibromyalgia(FM). This can make treatment decisions challenging in clinical practice as disease activity scores can…
  • Abstract Number: 155 • 2015 ACR/ARHP Annual Meeting

    Absence of Clinical and Ultrasound Activity of Hand and Foot: Is That Possible?: Experience in an Argentinian Rheumatoid Arthritis Cohort 

    María Victoria Martire1, Gloria Crespo2, Diego Puente Trigo2, Vanesa Duarte2, Maritza Manzano2, Leandro Carlevaris Sr.2, Anastasia Secco2, Lida Santiago2, Marta Mamani2 and Lucila Marino Claverie2, 1Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 2Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina

    Background/Purpose: Currently, one of the main goals of rheumatoid arthritis (RA) treatment is to attain remission. Stricter criteria as CDAI, SDAI ACR/ EULAR Boolean have…
  • Abstract Number: 156 • 2015 ACR/ARHP Annual Meeting

    Usefulness of the Stricter Remission Criteria for Assessing the Absence of Subclinical Activity in Rheumatoid Arthritis

    María Victoria Martire1, Maritza Manzano2, Diego Puente Trigo2, Vanesa Duarte2, Gloria Crespo2, Leandro Carlevaris Sr.2, Anastasia Secco2, Marta Mamani2, Lida Santiago2 and Lucila Marino Claverie1, 1Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 2Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina

    Background/Purpose: It has been seen that patients with rheumatoid arthritis (RA) who achieve remission measured by DAS28 persist with subclinical synovitis in hands and toes when…
  • Abstract Number: 157 • 2015 ACR/ARHP Annual Meeting

    Agreement Between DAS28, ACR/EULAR, SDAI, CDAI and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care

    Cecilie Heegaard Brahe1, Lene Terslev2, Simon Krabbe3, Mikkel Østergaard4, Henrik Rogind5, Hanne Jensen6, Annette Hansen7, Jesper Nørregaard8, Søren Jacobsen9, Karen Ellegaard10, Viktoria Fana1, Lars Juul7, Tuan K. Huynh8, Dorte V. Jensen7, Natalia Manilo6, Karsten Heller Asmussen6, Per Brown-Frandsen9, Søren Tobias Torp-Pedersen11, Niels Steen Krogh12 and Merete Lund Hetland2, 1Center for Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 2Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 3Center for Rheumatology and Spine diseases, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 4Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 5Center for Rheumatology and Spine Diseases, Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 6Department of Rheumatology, Copenhagen University Hospital at Frederiksberg-Bispebjerg, Denmark, Frederiksberg, Denmark, 7Department of Rheumatology, Copenhagen University Hospital at Gentofte - Herlev, Denmark, Gentofte, Denmark, 8Department of Rheumatology, Copenhagen University Hospital at Nordsjælland, Denmark, Hillerød, Denmark, 9Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Denmark, Glostrup, Denmark, 10Department of rheumatology, Frederiksberg-Bispebjerg Hospital, The Parker Institute, Copenhagen, Denmark, 11Department of Radiology, Copenhagen University Hospital at Glostrup, Denmark, Glostrup, Denmark, 12ZiteLab ApS, Copenhagen, Denmark

    Background/Purpose: Different remission criteria are available for patients with rheumatoid arthritis (RA). None of the criteria includes imaging remission, even though studies have shown that…
  • « Previous Page
  • 1
  • …
  • 1879
  • 1880
  • 1881
  • 1882
  • 1883
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology